Literature DB >> 17145364

Current diagnosis and management of fetal genitourinary abnormalities.

Katherine C Hubert1, Jeffrey S Palmer.   

Abstract

Prenatal assessment with ultrasonography provides excellent imaging of fluid-filled structures (eg, hydronephrosis, renal cysts, and dilated bladder) and renal parenchyma. This information allows for the generation of a differential diagnosis, identification of associated anomalies, and assessment of the prenatal and postnatal risks of a given anomaly. This enhances parental education and prenatal and postnatal planning. This article discusses the current methods of diagnosis and management of fetal genitourinary anomalies, and also the postnatal evaluation and treatment of these conditions.

Entities:  

Mesh:

Year:  2007        PMID: 17145364     DOI: 10.1016/j.ucl.2006.10.002

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  4 in total

1.  Ultrasound Scanning in Fetal Renal Pelvis Dilatation: not only Hydronephrosis.

Authors:  Alessandro Cavaliere; Santina Ermito; Alessia Mammaro; Angela Dinatale; Manuela Chiara Accardi; Elisa Maria Pappalardo; Stefania Recupero
Journal:  J Prenat Med       Date:  2009-10

2.  Babies with myelomeningocele in Poland: parents' attitudes on fetal surgery versus termination of pregnancy.

Authors:  Tomasz Koszutski; Henryk Kawalski; Grzegorz Kudela; Jolanta Wróblewska; Katarzyna Byrka-Owczarek; Janusz Bohosiewicz
Journal:  Childs Nerv Syst       Date:  2008-06-17       Impact factor: 1.475

Review 3.  Interactions between cytokines, congenital anomalies of kidney and urinary tract and chronic kidney disease.

Authors:  Ana Cristina Simões e Silva; Flávia Cordeiro Valério; Mariana Affonso Vasconcelos; Débora Marques Miranda; Eduardo Araújo Oliveira
Journal:  Clin Dev Immunol       Date:  2013-08-26

Review 4.  Chemokines as potential markers in pediatric renal diseases.

Authors:  Ana Cristina Simões e Silva; André Barreto Pereira; Mauro Martins Teixeira; Antônio Lúcio Teixeira
Journal:  Dis Markers       Date:  2014-02-17       Impact factor: 3.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.